2023 Women’s Health M&A Overview

This week, Leslie Schrock, breaks down the future of fertility – what trends to look for and which markets to bet on.

Amboy Street invests in HerMD which offers menopause and sexual health care through a hybrid delivery model with in-person and virtual services.

This week Bayer Exec, Laura Clark-Kelly, speaks to the complex nature of obtaining insurance coverage for women’s health and sexual wellness companies.

Amboy Street Ventures is excited to announce its latest investment in Evvy, the at-home vaginal microbiome testing and care company, leveraging female-specific biomarkers to radically reinvent how we understand and treat the female body.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space. This week we take a look at private equity funds buying women’s health and sexual wellness companies.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space. This week we take a look at established healthcare giants acquiring women’s health and sexual health innovation.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space. This week we take a look at late stage venture-backed companies growing through M&A.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space. This week we take a look at CPG conglomerates acquiring innovation.

Amboy Street Ventures’ Top 10 Deals of 2022 series looks at this year’s four major M&A trends in the women’s health and sexual health space.